WASHINGTON, March 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading ...

Danaher (DHR) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this industrial and medical device maker have returned +0.4% over the past month versus the Zacks S&P 500 composite's +3.6% change. The Zacks Diversified Operations industry, to which Danaher belongs, has gained 6.5% over this period. Now the key question is: Where could the stock be headed in ...

Danaher (DHR) closed the most recent trading day at $251.47, moving +0.83% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.63% for the day. Meanwhile, the Dow experienced a rise of 0.2%, and the technology-dominated Nasdaq saw an increase of 0.82%.The industrial and medical device maker's shares have seen a decrease of 0.24% over the last month, not keeping up with the Conglomerates sector's gain of 5.08% and the S&P 500's gain of 1.76%.Analysts and investors ...

Danaher Corporation (DHR) has been benefiting from strength in its Life Sciences segment driven by stable demand in the academic and life science research markets. Growth in demand for plasmids, proteins, gene writing and editing solutions augurs well for the segment.The company has been witnessing positive responses from its new products like IDBS' Polar Insight and Molecular Devices' CellXpress.ai, which help accelerate the drug discovery process and bring new therapies to market faster. Also, in the Diag ...

In the latest trading session, Danaher (DHR) closed at $252.80, marking a -0.35% move from the previous day. This change lagged the S&P 500's 0.11% loss on the day. At the same time, the Dow added 0.12%, and the tech-heavy Nasdaq lost 0.41%.Shares of the industrial and medical device maker have appreciated by 4.42% over the course of the past month, underperforming the Conglomerates sector's gain of 7.86% and outperforming the S&P 500's gain of 2.7%.Analysts and investors alike will be keeping a close eye o ...

Danaher Corporation (NYSE:DHR) TD Cowen 44th Annual Health Care Conference March 5, 2024 11:10 AM ET Company Participants Rainer Blair - President, CEO Conference Call Participants Dan Brennan - TD Cowen Dan Brennan Thank you. Dan Brennan from TD Cowen Life Science Tools Diagnostics. And we're here at 44th Annual Global Healthcare Conference. Really pleased to be joined here on the stage Rainer Blair, President and CEO of Danaher Corporation. So Rainer, thank you very much for being here. Rainer Blair Thank ...

Danaher (DHR) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this industrial and medical device maker have returned +3.3% over the past month versus the Zacks S&P 500 composite's +5.2% change. The Zacks Diversified Operations industry, to which Danaher belongs, has gained 6.7% over this period. Now the key question is: Where could the stock be headed in the near term?Althoug ...

A month has gone by since the last earnings report for Danaher (DHR) . Shares have added about 6.6% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Danaher due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Danaher Q4 Earnings Beat, Biotechnology Sales Dip Y/YDanaher’s ...

Danaher (DHR) ended the recent trading session at $255.71, demonstrating a +0.33% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss of 0.17%. Elsewhere, the Dow lost 0.06%, while the tech-heavy Nasdaq lost 0.55%.The industrial and medical device maker's shares have seen an increase of 4.05% over the last month, not keeping up with the Conglomerates sector's gain of 7.17% and outstripping the S&P 500's gain of 3.98%.The investment community will be paying ...

WASHINGTON, Feb. 22, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) emission reduction targets in line with the Science Based Targets initiative (SBTi), including a long-term target to reach net-zero value chain emissions by no later than 2050. Danaher's pledge encompasses Scope 1, 2 and 3 GHG emissions and complements its existing commitment to reduce Scope 1 and 2 GHG emissions on an absolute basis by 50.4% by 2032 ...